Healio - Dr. Douglas Dieterich: “Faldaprevir, Simeprevir Show Promise in HCV HIV Coinfected Patients”

 – March 4, 2013 /Press Release/  –– 

Two new protease inhibitors have shown potential in treating hepatitis C genotype 1 infection in patients coinfected with HIV. “Faldaprevir and simeprevir had similar [sustained virologic response] rates in coinfected patients as they did in mono-infected patients,” said Douglas Dieterich, MD, of The Icahn School of Medicine at Mount Sinai. The theme seems to be consistent, as there were similar data presented last year on telaprevir and boceprevir. Learn more